Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting
Felicia Rodriguez
June 22, 2021
via: https://www.biospace.com/article/roche-presents-positive-clinical-data-for-neurology-programs-at-ean-annual-meeting/ Roche presented results from several Phase II and III trials at the 7th Congress of the European Academy of Neurology (EAN) Annual Meeting held virtually June 19-22. Some of the results specifically underscored the efficacy and safety of EVRYSDI™ (risdiplam) for motor neuron disease, Enspryng® (satralizumab)